| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/18/2004 | EP1446105A1 Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods |
| 08/18/2004 | EP1446104A1 Spray drying methods and compositions thereof |
| 08/18/2004 | EP1446103A2 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 08/18/2004 | EP1446101A2 Catheter injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446099A1 Injectable depot composition |
| 08/18/2004 | EP1446096A1 Topical compositions containing enzymes stabilised with inhibitors |
| 08/18/2004 | EP1446093A1 Potentiated topical composition |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446086A1 Compositions containing oils having a specific gravity higher than the specific gravity of water |
| 08/18/2004 | EP1446045A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 08/18/2004 | EP1446010A2 Stabilized azithromycin compositions |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1446007A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 08/18/2004 | EP1395273A4 Targeted delivery of drugs for the treatment of viral infections |
| 08/18/2004 | EP1315739B1 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 08/18/2004 | EP1294479B1 Method for producing capsules containing an active ingredient and having an ultra-thin coating |
| 08/18/2004 | EP1232100B1 Injection-moulded water-soluble container |
| 08/18/2004 | EP1202713B1 Artificial tear replacement solution |
| 08/18/2004 | EP1194109B1 Topical formulations comprising skin penetration agents and the use thereof |
| 08/18/2004 | EP1178833B1 Topical compositions for prostaglandin e 1 delivery |
| 08/18/2004 | EP1161458B1 Malatyl polysaccharides, their production and their use |
| 08/18/2004 | EP1117390B1 Mucosal originated drug delivery systems |
| 08/18/2004 | EP1094841B1 Pharmaceutical levothyroxine preparation |
| 08/18/2004 | EP1083882A4 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier |
| 08/18/2004 | EP1079803B1 Protein formulations |
| 08/18/2004 | EP1073671A4 Targeted gene delivery to cells by filamentous bacteriophage |
| 08/18/2004 | EP1045637A4 Decorated red blood cells |
| 08/18/2004 | EP1021155B1 Water dispersible perfluoroether polymer encapsulates |
| 08/18/2004 | EP1011610A4 Skin care compositions and use |
| 08/18/2004 | EP1004296B1 Powder containing fat-soluble drug |
| 08/18/2004 | EP0989957B1 Improved method for preparing low-concentration polyaluminosilicate microgels |
| 08/18/2004 | EP0955064B1 Process for producing drug complexes |
| 08/18/2004 | EP0946744B1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes |
| 08/18/2004 | EP0946621B1 Cationic film-forming polymer compositions containing same, and uses thereof, including topical delivery system and method of delivering agents to the skin and hair |
| 08/18/2004 | EP0916348B1 alkyldextran-polyalcohol drug complexes |
| 08/18/2004 | EP0881899B1 Dosage form of ibuprofen |
| 08/18/2004 | EP0877622B1 Method of inactivation of ras subfamily proteins and agents therefor |
| 08/18/2004 | CN1522516A Secure header information for multi-content e-mail |
| 08/18/2004 | CN1522159A Interferon formulations |
| 08/18/2004 | CN1522156A Novel engineered superantigen for human therapy |
| 08/18/2004 | CN1522154A Vaccines including as an adjuvant type 1 IFN and process related thereto |
| 08/18/2004 | CN1522153A Novel composition |
| 08/18/2004 | CN1522150A Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
| 08/18/2004 | CN1522145A Compositions and methods for treating vulvovaginitis and vaginosis |
| 08/18/2004 | CN1522140A Oxcarbazepine dosage forms |
| 08/18/2004 | CN1522132A Composition for freshening nostrils and sinus cavities |
| 08/18/2004 | CN1520805A Ubiquinone containing composition |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/18/2004 | CN1162157C Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 08/18/2004 | CN1162148C Thermal gel drug delivery vehicles containing cellulose ethers |
| 08/18/2004 | CN1162141C Formulations for reducing skin irritation and use |
| 08/17/2004 | US6777450 Non-phospholipid, non-ethoxylated ?pseudoemulsifier? having a chemical composition comprising at least one hydrophobic moiety, and at least one polar moiety |
| 08/17/2004 | US6777448 Rafoxanide, for the treatment of parasitic diseases in farm and domestic animals, like the liver fluke or bot fly infestations |
| 08/17/2004 | US6777444 Nordihydroguaiaretic acid; anticancer agents, viricides |
| 08/17/2004 | US6777436 Synergistic mixture of angiotensin inhibitors, boric acid, ethylenediaminetetraacetic acid and active drug |
| 08/17/2004 | US6777429 Ophthalmic composition |
| 08/17/2004 | US6777401 Solution comprising: a) water; b) propylene glycol; c) 2-propanol; and d) hydrocortisone; dispensing solution into an external ear canal and contacting a wick with the solution to expand the wick within the canal |
| 08/17/2004 | US6777399 Anti-inflammatory androstane derivative compositions |
| 08/17/2004 | US6777386 Peptide agonist or analogue other than deslorelin; lecithin and stearin; preferably comprises a gnrh agonist and is used for the treatment of various conditions where suppression of sex hormone levels is beneficial |
| 08/17/2004 | US6777237 Bioconjugate comprises the bioactive agent and an organocobalt complex |
| 08/17/2004 | US6777195 Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants |
| 08/17/2004 | US6777191 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in diagnosis of viral infection |
| 08/17/2004 | US6777002 Process for microencapsulation of water soluble substances |
| 08/17/2004 | US6777000 Sustained release |
| 08/17/2004 | US6776999 Expandable gastroretentive therapeutical system with prolonged stomach retention time |
| 08/17/2004 | US6776990 Methods and compositions for the treatment of pancreatitis |
| 08/17/2004 | US6776982 Autoclavable pharmaceutical compositions containing a chelating agent |
| 08/17/2004 | US6776978 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc. |
| 08/17/2004 | US6776976 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/17/2004 | US6776796 Antiinflammatory drug and delivery device |
| 08/17/2004 | US6776164 Enhanced intravaginal devices |
| 08/17/2004 | CA2253980C Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/17/2004 | CA2133177C Rapamycin formulations for oral administration |
| 08/17/2004 | CA2133175C Rapamycin formulations for oral administration |
| 08/17/2004 | CA2087679C The process for transport of agents across the skin and compositions and articles useful therein |
| 08/12/2004 | WO2004067678A1 Antioxidative composition and composition for external use |
| 08/12/2004 | WO2004067039A1 Multiparticulate compositions of milnacipran for oral administration |
| 08/12/2004 | WO2004067038A1 Anthracycline-antibody conjugates |
| 08/12/2004 | WO2004067037A1 Intestinal environment controlling agent for oral use and normal intestinal flora growing kit for oral use |
| 08/12/2004 | WO2004067036A1 Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 08/12/2004 | WO2004067005A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | WO2004066998A1 Stable solid medicinal composition for oral administration |
| 08/12/2004 | WO2004066989A1 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide comp lexes |
| 08/12/2004 | WO2004066971A1 Composition for preventive treatment of cold sores |
| 08/12/2004 | WO2004066946A2 Method for evaluating the efficacy of certain cancer treatments |
| 08/12/2004 | WO2004066938A2 Method and composition for lowering cholesterol |
| 08/12/2004 | WO2004066925A2 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same |
| 08/12/2004 | WO2004066908A2 Composition containing cationic lipids and a polynucleotide or a polypeptide and method for the targeted delivery of active substances |
| 08/12/2004 | WO2004066750A1 Novel compositions comprising carotenoids |
| 08/12/2004 | WO2004056858A3 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 08/12/2004 | WO2004056311A3 Stimuli-responsive systems for controlled drug delivery |
| 08/12/2004 | WO2004052287A3 Topical composition for heightened sensitivity |
| 08/12/2004 | WO2004045718A3 Treatment of cognitive dysfunctions' |
| 08/12/2004 | WO2004045506A3 Conjugated fatty acid based emulsion and methods for preparing and using same |
| 08/12/2004 | WO2004043396A3 Modified carbamate-containing prodrugs and methods of synthesizing same |
| 08/12/2004 | WO2004043363A3 Protein-stabilized liposomal formulations of pharmaceutical agents |
| 08/12/2004 | WO2004041923A3 Chemoenzymatically hydrolysable biologically active compounds |
| 08/12/2004 | WO2004041869A3 Reactive polymers having chemoenzymatically hydrolysable functional groups |